Added to YB: 2026-08-27
Pitch date: 2026-08-25
PRPO [neutral]
Precipio, Inc.
-0.08%
current return
Author Info
No bio for this author
Company Info
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.
Market Cap
$55.7M
Pitch Price
$30.43
Price Target
N/A
Dividend
N/A
EV/EBITDA
151.55
P/E
-44.65
EV/Sales
2.07
Sector
Health Care Providers and Services
Category
growth
Weekly #18: Most Interesting D-Sheets from the Past Week (Aug 18 – Aug 24, 2026) - PRPO — Precipio, Inc. - Moderate Signal
PRPO (earnings): Q2'26 inflection: first-ever revenue >$7M (+22% YoY), positive adj EBITDA, $0.7M op cash flow, no equity raise; self-funded, cash >$3M, ~$41M mcap. Product rev +~35% seq (higher-margin lines); one-day AML diagnostic gaining interest. Info arb: 2H distributor-conversion opportunity disclosed only on call, not release; ~10 added reps, 25+ qualified customers. Risks: pipeline conversion unproven, product rev lumpy, mgmt conceded adj EBITDA gain not entirely operational.
Read full article (1 min)